Pharmacokinetic considerations in phenytoin pharmacotherapy: preventing overdoses and underdoses.
Profeta
L M
LM
Department of Pharmacy, Mount Sinai Medical Center, New York, NY 10029, USA.
Bradbury
K
K
Mehl
B
B
D058186:Acute Kidney Injury / Q000378:metabolism; D000927:Anticonvulsants / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism; D008991:Monitoring, Physiologic; D010672:Phenytoin / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D012709:Serum Albumin / Q000032:analysis; D013997:Time Factors
D000927:Anticonvulsants; D012709:Serum Albumin; D010672:Phenytoin